• Q4 EPS Estimate for ARS Pharmaceuticals Boosted by Analyst

    Source: Buzz FX / 15 Nov 2024 09:41:18   America/Chicago


    Q4 EPS Estimate for ARS Pharmaceuticals Boosted by Analyst Written by MarketBeat November 15, 2024 Share Link copied to clipboard. ARS Pharmaceuticals, Inc. ( NASDAQ:SPRY - Free Report ) - Research analysts at William Blair boosted their Q4
    Read more...
Share on,